ChemoCentryx's IPO

ChemoCentryx raised a round of funding on February 08, 2012. Investors include Public.

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The…

Articles about ChemoCentryx's IPO: